Page last updated: 2024-08-25

tocophersolan and n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine

tocophersolan has been researched along with n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Jimenez-Del-Rio, M; Mendivil-Perez, M; Velez-Pardo, C2

Other Studies

2 other study(ies) available for tocophersolan and n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine

ArticleYear
Combinational treatment of TPEN and TPGS induces apoptosis in acute lymphoblastic and chronic myeloid leukemia cells in vitro and ex vivo.
    Medical oncology (Northwood, London, England), 2022, May-17, Volume: 39, Issue:7

    Topics: Apoptosis; Child; Ethylenediamines; Humans; Jurkat Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Signal Transduction; Vitamin E

2022
TPEN/TPGS (T2) combo dramatically reduces Philadelphia chromosome-positive pro-lymphoblastic B leukemia in BALB/c mice.
    Medical oncology (Northwood, London, England), 2022, Nov-09, Volume: 40, Issue:1

    Topics: Adult; Animals; Fusion Proteins, bcr-abl; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Mice, Inbred BALB C; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma

2022